WHO clinical treatment guideline for tobacco cessation in adults / World Health Organization.

Format:

Book

Author/Creator:

World Health Organization, author, issuing body.

Language:

English

Subjects (All):

Nicotine addiction--Treatment.

Nicotine addiction.

Physical Description:

1 online resource (xiv, 53 pages) : illustrations

Place of Publication:

Geneva, Switzerland : World Health Organization, 2024.

Summary:

This guideline seeks to provide evidence-based recommendations on the use of home-based records for MNCH outcomes. This will enable country-level decision-makers and health care providers to better understand the value of home-based records, their impact on a broad set of outcomes, and their potential contribution to strengthening the quality of health service delivery and health systems. It is intended to be used by policy-makers and programme managers to help them decide whether home-based records should feature more prominently in their MCH programmes, and to encourage more effective implementation.

Contents:

Acknowledgements

Abbreviations and acronyms

Glossary of terms

Executive summary

1. Introduction

1.1. Existing WHO guidelines

1.2. Rationale and objectives

1.3. Target audience

2. Methods

2.1. Scope of the guideline and questions of interest

2.2. Evidence reviews

2.3. Assessment of evidence and its grading

2.4. Going from evidence to recommendations

3. Recommendations

3.1. Behavioural support delivered in both clinical and community settings

3.2. Digital tobacco cessation interventions

3.3. Pharmacological interventions delivered in both clinical and community settings

3.4. Interventions for smokeless tobacco use cessation

3.5. Combination of behavioural and pharmacological treatments

3.6. Traditional, complementary and alternative therapies

3.7. System-level interventions and policies

3.8. Overarching guideline implementation considerations

4. Evidence to recommendations

4.1. Assessment of the certainty of evidence

4.2. Benefits and harms

4.3. Values and preferences

4.4. Cost-effectiveness and resource requirements

4.5. Equity, acceptability and feasibility

5. Research needs

General

Policy

Systems

Counselling interventions

Digital interventions

Medications

Cost and cost-effectiveness

Strategies and methods

Products

6. Adoption, dissemination, implementation and evaluation

References

Annexes

Annex 1. Management of guideline development process

Annex 2. Additional information for implementing the recommendations

Annex 3. Summary of declarations of interest and how these were managed

Web Annex. Evidence profiles.

Notes:

Description based on publisher supplied metadata and other sources.